Skip to content
Delayed ~15 min

IMNM IMMUNOME

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Tue 10 Nov 2026 · estimated

What 20 analyst firms say about IMMUNOME: their latest ratings, price targets and how far the stock is from them. How it works

18.71 USD+0.81 (+4.50%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+85.5%to the avg target 34.71 USD+16.00 USD
Buy 17 · Hold 2 · Sell 0

19 rated views · 20 analyst/firm records · 20 firms

Latest report27 Oct 2026avg report date 23 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MGood · #35 in the index88
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8070

Recent analyst activity · last 90 days

Our tracked history has 14 reports on IMNM from 10 analyst firms in the last 90 days (20 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target, 5 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Truist Securities raised its target from $37.00 (set 28 May 2026) to $38.00 on 12 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Alliance Global PartnersMatthew VeneziaBuy21 Sep 202632.00 USD
BarclaysLukas ShumwayBuy1 Oct 202636.00 USD
CitigroupUnnamed analystBuy9 Jul 2026—
Craig-HallumAdam VogelBuy29 Apr 202636.00 USD
Evercore ISICory KasimovBuy1 Jul 202640.00 USD
Goldman SachsSalveen RichterBuy25 Jun 202637.00 USD
GuggenheimMichael SchmidtBuy13 Aug 202635.00 USD
H.C. WainwrightAndres Y. MaldonadoBuy27 Oct 202640.00 USD
Lake Street Capital MarketsChad MesserBuy1 Jun 202630.00 USD
Leerink PartnersAndrew BerensBuy15 May 202633.00 USD
Lifesci CapitalCharles ZhuBuy11 Jun 202640.00 USD
Piper SandlerBiren AminBuy12 Aug 2026—
StephensSudan LoganathanBuy4 Mar 202630.00 USD
StifelDara AzarHold30 Sep 202624.00 USD
TD CowenTyler Van BurenBuy24 Mar 2026—
TruistSupawat ThongthipBuy12 Aug 202638.00 USD
WedbushDavid NierengartenBuy27 Oct 202635.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
William BlairAlethia YoungBuy16 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 05:50 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.